ICSMA-20-170-04
Vulnerability from csaf_cisa - Published: 2020-06-18 00:00 - Updated: 2020-06-23 00:00Summary
Baxter Sigma Spectrum Infusion Pumps (Update B)
Notes
CISA Disclaimer
This CSAF advisory was extracted from unstructured data and may contain inaccuracies. If you notice any errors, please reach out to the designated contact at CISA CSAF: central@cisa.dhs.gov
Legal Notice
All information products included in https://us-cert.cisa.gov/ics are provided "as is" for informational purposes only. The Department of Homeland Security (DHS) does not provide any warranties of any kind regarding any information contained within. DHS does not endorse any commercial product or service, referenced in this product or otherwise. Further dissemination of this product is governed by the Traffic Light Protocol (TLP) marking in the header. For more information about TLP, see https://us-cert.cisa.gov/tlp/.
Risk evaluation
Successful exploitation of these vulnerabilities could result in access to sensitive data, alteration of system configuration, and impact to system availability.
Critical infrastructure sectors
Healthcare and Public Health
Countries/areas deployed
United States
Company headquarters location
United States
Recommended Practices
CISA recommends users take defensive measures to minimize the risk of exploitation of this vulnerability. Specifically, users should: Minimize network exposure for all control system devices and/or systems, and ensure they are not accessible from the Internet; Locate control system networks and remote devices behind firewalls and isolate them from the business network; When remote access is required, use secure methods, such as Virtual Private Networks (VPNs), recognizing VPNs may have vulnerabilities and should be updated to the most current version available. Also recognize VPN is only as secure as its connected devices.
Recommended Practices
CISA reminds organizations to perform proper impact analysis and risk assessment prior to deploying defensive measures.
CISA also provides a section for control systems security recommended practices on the ICS webpage on cisa.gov. Several recommended practices are available for reading and download, including Improving Industrial Control Systems Cybersecurity with Defense-in-Depth Strategies.
Recommended Practices
Additional mitigation guidance and recommended practices are publicly available on the ICS webpage on cisa.gov in the Technical Information Paper, ICS-TIP-12-146-01B--Targeted Cyber Intrusion Detection and Mitigation Strategies.
Organizations observing any suspected malicious activity should follow their established internal procedures and report their findings to CISA for tracking and correlation against other incidents.
Exploitability
No known public exploits specifically target these vulnerabilities.
{
"document": {
"acknowledgments": [
{
"organization": "Baxter Healthcare",
"summary": "reporting these vulnerabilities to CISA"
}
],
"category": "csaf_security_advisory",
"csaf_version": "2.0",
"distribution": {
"text": "Disclosure is not limited",
"tlp": {
"label": "WHITE",
"url": "https://us-cert.cisa.gov/tlp/"
}
},
"lang": "en-US",
"notes": [
{
"category": "general",
"text": "This CSAF advisory was extracted from unstructured data and may contain inaccuracies. If you notice any errors, please reach out to the designated contact at CISA CSAF: central@cisa.dhs.gov",
"title": "CISA Disclaimer"
},
{
"category": "legal_disclaimer",
"text": "All information products included in https://us-cert.cisa.gov/ics are provided \"as is\" for informational purposes only. The Department of Homeland Security (DHS) does not provide any warranties of any kind regarding any information contained within. DHS does not endorse any commercial product or service, referenced in this product or otherwise. Further dissemination of this product is governed by the Traffic Light Protocol (TLP) marking in the header. For more information about TLP, see https://us-cert.cisa.gov/tlp/.",
"title": "Legal Notice"
},
{
"category": "summary",
"text": "Successful exploitation of these vulnerabilities could result in access to sensitive data, alteration of system configuration, and impact to system availability.",
"title": "Risk evaluation"
},
{
"category": "other",
"text": "Healthcare and Public Health",
"title": "Critical infrastructure sectors"
},
{
"category": "other",
"text": "United States",
"title": "Countries/areas deployed"
},
{
"category": "other",
"text": "United States",
"title": "Company headquarters location"
},
{
"category": "general",
"text": "CISA recommends users take defensive measures to minimize the risk of exploitation of this vulnerability. Specifically, users should: Minimize network exposure for all control system devices and/or systems, and ensure they are not accessible from the Internet; Locate control system networks and remote devices behind firewalls and isolate them from the business network; When remote access is required, use secure methods, such as Virtual Private Networks (VPNs), recognizing VPNs may have vulnerabilities and should be updated to the most current version available. Also recognize VPN is only as secure as its connected devices.",
"title": "Recommended Practices"
},
{
"category": "general",
"text": "CISA reminds organizations to perform proper impact analysis and risk assessment prior to deploying defensive measures.\nCISA also provides a section for control systems security recommended practices on the ICS webpage on cisa.gov. Several recommended practices are available for reading and download, including Improving Industrial Control Systems Cybersecurity with Defense-in-Depth Strategies.",
"title": "Recommended Practices"
},
{
"category": "general",
"text": "Additional mitigation guidance and recommended practices are publicly available on the ICS webpage on cisa.gov in the Technical Information Paper, ICS-TIP-12-146-01B--Targeted Cyber Intrusion Detection and Mitigation Strategies.\nOrganizations observing any suspected malicious activity should follow their established internal procedures and report their findings to CISA for tracking and correlation against other incidents.",
"title": "Recommended Practices"
},
{
"category": "other",
"text": "No known public exploits specifically target these vulnerabilities.",
"title": "Exploitability"
}
],
"publisher": {
"category": "coordinator",
"contact_details": "Email: CISAservicedesk@cisa.dhs.gov;\n Toll Free: 1-888-282-0870",
"name": "CISA",
"namespace": "https://www.cisa.gov/"
},
"references": [
{
"category": "self",
"summary": "ICS Advisory ICSMA-20-170-04 JSON",
"url": "https://raw.githubusercontent.com/cisagov/CSAF/develop/csaf_files/OT/white/2020/icsma-20-170-04.json"
},
{
"category": "self",
"summary": "ICS Advisory ICSMA-20-170-04 Web Version",
"url": "https://www.cisa.gov/news-events/ics-medical-advisories/icsma-20-170-04"
},
{
"category": "external",
"summary": "Recommended Practices",
"url": "https://www.cisa.gov/uscert/ics/alerts/ICS-ALERT-10-301-01"
},
{
"category": "external",
"summary": "Recommended Practices",
"url": "https://www.cisa.gov/uscert/sites/default/files/recommended_practices/NCCIC_ICS-CERT_Defense_in_Depth_2016_S508C.pdf"
},
{
"category": "external",
"summary": "Recommended Practices",
"url": "https://www.cisa.gov/uscert/ics/tips/ICS-TIP-12-146-01B"
}
],
"title": "Baxter Sigma Spectrum Infusion Pumps (Update B)",
"tracking": {
"current_release_date": "2020-06-23T00:00:00.000000Z",
"generator": {
"engine": {
"name": "CISA CSAF Generator",
"version": "1.0.0"
}
},
"id": "ICSMA-20-170-04",
"initial_release_date": "2020-06-18T00:00:00.000000Z",
"revision_history": [
{
"date": "2020-06-18T00:00:00.000000Z",
"legacy_version": "Initial",
"number": "1",
"summary": "ICSMA-20-170-04 Baxter Spectrum Infusion Pumps"
},
{
"date": "2020-06-23T00:00:00.000000Z",
"legacy_version": "A",
"number": "2",
"summary": "ICSMA-20-170-04 Baxter Spectrum Infusion (Update A)"
}
],
"status": "final",
"version": "2"
}
},
"product_tree": {
"branches": [
{
"branches": [
{
"branches": [
{
"category": "product_version",
"name": "v8.x model 35700BAX2",
"product": {
"name": "Baxter Spectrum: v8.x model 35700BAX2",
"product_id": "CSAFPID-0001"
}
}
],
"category": "product_name",
"name": "Baxter Spectrum"
},
{
"branches": [
{
"category": "product_version_range",
"name": "v6.x (with Wireless Battery Modules v9 | v11 | v13 | v14 | v15 | v16 | v16D38 | v17 | v17D19 | \u003e= v20D29 | \u003c= v20D32 | \u003e= v22D24 | \u003c= v22D28)",
"product": {
"name": "Sigma Spectrum LVP: v6.x with Wireless Battery Modules v9 v11 v13 v14 v15 v16 v16D38 v17 v17D19 v20D29 to v20D32 and v22D24 to v22D28",
"product_id": "CSAFPID-0002"
}
}
],
"category": "product_name",
"name": "Sigma Spectrum LVP"
},
{
"branches": [
{
"category": "product_version",
"name": "v6.x model 35700BAX",
"product": {
"name": "Sigma Spectrum: v6.x model 35700BAX",
"product_id": "CSAFPID-0003"
}
}
],
"category": "product_name",
"name": "Sigma Spectrum"
},
{
"branches": [
{
"category": "product_version_range",
"name": "v8.x (with Wireless Battery Modules v17 | v17D19 | \u003e= v20D29 | \u003c= v20D32 | \u003e= v22D24 | \u003c= v22D28)",
"product": {
"name": "Baxter Spectrum LVP: v8.x with Wireless Battery Modules v17 v17D19 v20D29 to v20D32 and v22D24 to v22D28",
"product_id": "CSAFPID-0004"
}
}
],
"category": "product_name",
"name": "Baxter Spectrum LVP"
},
{
"branches": [
{
"category": "product_version",
"name": "v9.x model 35700BAX3",
"product": {
"name": "Baxter Spectrum: v9.x model 35700BAX3",
"product_id": "CSAFPID-0005"
}
}
],
"category": "product_name",
"name": "Baxter Spectrum"
},
{
"branches": [
{
"category": "product_version_range",
"name": "v9.x (with Wireless Battery Module \u003e= v22D19 | \u003c= v22D28)",
"product": {
"name": "Baxter Spectrum LVP: v9.x with Wireless Battery Module v22D19 to v22D28",
"product_id": "CSAFPID-0006"
}
}
],
"category": "product_name",
"name": "Baxter Spectrum LVP"
}
],
"category": "vendor",
"name": "Baxter"
}
]
},
"vulnerabilities": [
{
"cve": "CVE-2020-12039",
"cwe": {
"id": "CWE-259",
"name": "Use of Hard-coded Password"
},
"notes": [
{
"category": "summary",
"text": "Sigma Spectrum Infusion System Version(s) 6.x (model 35700BAX) and Baxter Spectrum Infusion System Version(s) 8.x (model 35700BAX2) contain hard-coded passwords which, when physically entered on the keypad, provide access to biomedical menus that include device settings, view of calibration values, and network configuration of the Sigma Spectrum Wireless Battery Module (WBM) if installed. CVE-2020-12039 has been assigned to this vulnerability. A CVSS v3 base score of 4.3 has been calculated; the CVSS vector string is (AV:P/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:L).",
"title": "Vulnerability Summary"
}
],
"product_status": {
"known_affected": [
"CSAFPID-0001",
"CSAFPID-0002",
"CSAFPID-0003",
"CSAFPID-0004",
"CSAFPID-0005",
"CSAFPID-0006"
]
},
"references": [
{
"category": "external",
"summary": "web.nvd.nist.gov",
"url": "http://web.nvd.nist.gov/view/vuln/detail?vulnId=CVE-2020-12039"
},
{
"category": "external",
"summary": "www.first.org",
"url": "https://www.first.org/cvss/calculator/3.0#CVSS:3.0/AV:P/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:L"
}
],
"remediations": [
{
"category": "vendor_fix",
"details": "Baxter recommends ensuring appropriate physical controls within user environments to protect against unauthorized access to devices.",
"product_ids": [
"CSAFPID-0001",
"CSAFPID-0002",
"CSAFPID-0003",
"CSAFPID-0004",
"CSAFPID-0005",
"CSAFPID-0006"
]
},
{
"category": "vendor_fix",
"details": "Baxter recommends isolating the Spectrum Infusion Systems to its own network VLAN to segregate the system from other hospital systems, and reduce the probability that a threat actor could execute an adjacent attack such as a MiTM attack against the system to observe clear-text communications.",
"product_ids": [
"CSAFPID-0001",
"CSAFPID-0002",
"CSAFPID-0003",
"CSAFPID-0004",
"CSAFPID-0005",
"CSAFPID-0006"
]
},
{
"category": "vendor_fix",
"details": "Baxter recommends using the strongest available wireless network security protocols (e.g., WPA2, EAP-TLS, etc.) to provide authentication and encryption of wireless data sent to and from the Spectrum Infusion System.",
"product_ids": [
"CSAFPID-0001",
"CSAFPID-0002",
"CSAFPID-0003",
"CSAFPID-0004",
"CSAFPID-0005",
"CSAFPID-0006"
]
},
{
"category": "vendor_fix",
"details": "Users should ensure the WBM is rebooted after configuration for their network(s) by removing the WBM from the rear of the Spectrum device for 10-15 seconds, and then re-attaching the WBM.",
"product_ids": [
"CSAFPID-0001",
"CSAFPID-0002",
"CSAFPID-0003",
"CSAFPID-0004",
"CSAFPID-0005",
"CSAFPID-0006"
]
},
{
"category": "vendor_fix",
"details": "Users should always monitor for and/or block unexpected traffic, such as FTP, at network boundaries into the Spectrum-specific VLAN.",
"product_ids": [
"CSAFPID-0001",
"CSAFPID-0002",
"CSAFPID-0003",
"CSAFPID-0004",
"CSAFPID-0005",
"CSAFPID-0006"
]
},
{
"category": "vendor_fix",
"details": "As a last resort, users may disable wireless operation of the pump. The Spectrum Infusion System was designed to operate without network access. This action would impact an organization \u0027s ability to rapidly deploy drug library (formulary) updates to their pumps.",
"product_ids": [
"CSAFPID-0001",
"CSAFPID-0002",
"CSAFPID-0003",
"CSAFPID-0004",
"CSAFPID-0005",
"CSAFPID-0006"
]
},
{
"category": "vendor_fix",
"details": "For additional information please see the Baxter Product Security Bulletin.",
"product_ids": [
"CSAFPID-0001",
"CSAFPID-0002",
"CSAFPID-0003",
"CSAFPID-0004",
"CSAFPID-0005",
"CSAFPID-0006"
],
"url": "https://www.baxter.com/product-security#additionalresources"
}
],
"scores": [
{
"cvss_v3": {
"baseScore": 4.3,
"baseSeverity": "MEDIUM",
"vectorString": "CVSS:3.0/AV:P/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:L",
"version": "3.0"
},
"products": [
"CSAFPID-0001",
"CSAFPID-0002",
"CSAFPID-0003",
"CSAFPID-0004",
"CSAFPID-0005",
"CSAFPID-0006"
]
}
]
},
{
"cve": "CVE-2020-12040",
"cwe": {
"id": "CWE-319",
"name": "Cleartext Transmission of Sensitive Information"
},
"notes": [
{
"category": "summary",
"text": "Sigma Spectrum Infusion System Version(s) 6.x (model 35700BAX) and Baxter Spectrum Infusion System Version(s) 8.x (model 35700BAX2) at the application layer uses an unauthenticated clear-text communication channel to send and receive system status and operational data. This could allow an attacker that has circumvented network security measures to view sensitive non-private data or to perform a man-in-the-middle attack. CVE-2020-12040 has been assigned to this vulnerability. A CVSS v3 base score of 7.3 has been calculated; the CVSS vector string is (AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:L).",
"title": "Vulnerability Summary"
}
],
"product_status": {
"known_affected": [
"CSAFPID-0001",
"CSAFPID-0002",
"CSAFPID-0003",
"CSAFPID-0004",
"CSAFPID-0005",
"CSAFPID-0006"
]
},
"references": [
{
"category": "external",
"summary": "web.nvd.nist.gov",
"url": "http://web.nvd.nist.gov/view/vuln/detail?vulnId=CVE-2020-12040"
},
{
"category": "external",
"summary": "www.first.org",
"url": "https://www.first.org/cvss/calculator/3.0#CVSS:3.0/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:L"
}
],
"remediations": [
{
"category": "vendor_fix",
"details": "Baxter recommends ensuring appropriate physical controls within user environments to protect against unauthorized access to devices.",
"product_ids": [
"CSAFPID-0001",
"CSAFPID-0002",
"CSAFPID-0003",
"CSAFPID-0004",
"CSAFPID-0005",
"CSAFPID-0006"
]
},
{
"category": "vendor_fix",
"details": "Baxter recommends isolating the Spectrum Infusion Systems to its own network VLAN to segregate the system from other hospital systems, and reduce the probability that a threat actor could execute an adjacent attack such as a MiTM attack against the system to observe clear-text communications.",
"product_ids": [
"CSAFPID-0001",
"CSAFPID-0002",
"CSAFPID-0003",
"CSAFPID-0004",
"CSAFPID-0005",
"CSAFPID-0006"
]
},
{
"category": "vendor_fix",
"details": "Baxter recommends using the strongest available wireless network security protocols (e.g., WPA2, EAP-TLS, etc.) to provide authentication and encryption of wireless data sent to and from the Spectrum Infusion System.",
"product_ids": [
"CSAFPID-0001",
"CSAFPID-0002",
"CSAFPID-0003",
"CSAFPID-0004",
"CSAFPID-0005",
"CSAFPID-0006"
]
},
{
"category": "vendor_fix",
"details": "Users should ensure the WBM is rebooted after configuration for their network(s) by removing the WBM from the rear of the Spectrum device for 10-15 seconds, and then re-attaching the WBM.",
"product_ids": [
"CSAFPID-0001",
"CSAFPID-0002",
"CSAFPID-0003",
"CSAFPID-0004",
"CSAFPID-0005",
"CSAFPID-0006"
]
},
{
"category": "vendor_fix",
"details": "Users should always monitor for and/or block unexpected traffic, such as FTP, at network boundaries into the Spectrum-specific VLAN.",
"product_ids": [
"CSAFPID-0001",
"CSAFPID-0002",
"CSAFPID-0003",
"CSAFPID-0004",
"CSAFPID-0005",
"CSAFPID-0006"
]
},
{
"category": "vendor_fix",
"details": "As a last resort, users may disable wireless operation of the pump. The Spectrum Infusion System was designed to operate without network access. This action would impact an organization \u0027s ability to rapidly deploy drug library (formulary) updates to their pumps.",
"product_ids": [
"CSAFPID-0001",
"CSAFPID-0002",
"CSAFPID-0003",
"CSAFPID-0004",
"CSAFPID-0005",
"CSAFPID-0006"
]
},
{
"category": "vendor_fix",
"details": "For additional information please see the Baxter Product Security Bulletin.",
"product_ids": [
"CSAFPID-0001",
"CSAFPID-0002",
"CSAFPID-0003",
"CSAFPID-0004",
"CSAFPID-0005",
"CSAFPID-0006"
],
"url": "https://www.baxter.com/product-security#additionalresources"
}
],
"scores": [
{
"cvss_v3": {
"baseScore": 7.3,
"baseSeverity": "HIGH",
"vectorString": "CVSS:3.0/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:L",
"version": "3.0"
},
"products": [
"CSAFPID-0001",
"CSAFPID-0002",
"CSAFPID-0003",
"CSAFPID-0004",
"CSAFPID-0005",
"CSAFPID-0006"
]
}
]
},
{
"cve": "CVE-2020-12045",
"cwe": {
"id": "CWE-259",
"name": "Use of Hard-coded Password"
},
"notes": [
{
"category": "summary",
"text": "The Baxter Spectrum WBM (v9, v11, v13, v14, v15, v16, v16D38, v17, v17D19, v20D29 to v20D32, and v22D19 to v22D28) operates a Telnet service with hard-coded credentials when connected to specific SSIDs. CVE-2020-12045 has been assigned to this vulnerability. A CVSS v3 base score of 8.6 has been calculated; the CVSS vector string is (AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:H).",
"title": "Vulnerability Summary"
}
],
"product_status": {
"known_affected": [
"CSAFPID-0001",
"CSAFPID-0002",
"CSAFPID-0003",
"CSAFPID-0004",
"CSAFPID-0005",
"CSAFPID-0006"
]
},
"references": [
{
"category": "external",
"summary": "web.nvd.nist.gov",
"url": "http://web.nvd.nist.gov/view/vuln/detail?vulnId=CVE-2020-12045"
},
{
"category": "external",
"summary": "www.first.org",
"url": "https://www.first.org/cvss/calculator/3.0#CVSS:3.0/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:H"
}
],
"remediations": [
{
"category": "vendor_fix",
"details": "Baxter recommends ensuring appropriate physical controls within user environments to protect against unauthorized access to devices.",
"product_ids": [
"CSAFPID-0001",
"CSAFPID-0002",
"CSAFPID-0003",
"CSAFPID-0004",
"CSAFPID-0005",
"CSAFPID-0006"
]
},
{
"category": "vendor_fix",
"details": "Baxter recommends isolating the Spectrum Infusion Systems to its own network VLAN to segregate the system from other hospital systems, and reduce the probability that a threat actor could execute an adjacent attack such as a MiTM attack against the system to observe clear-text communications.",
"product_ids": [
"CSAFPID-0001",
"CSAFPID-0002",
"CSAFPID-0003",
"CSAFPID-0004",
"CSAFPID-0005",
"CSAFPID-0006"
]
},
{
"category": "vendor_fix",
"details": "Baxter recommends using the strongest available wireless network security protocols (e.g., WPA2, EAP-TLS, etc.) to provide authentication and encryption of wireless data sent to and from the Spectrum Infusion System.",
"product_ids": [
"CSAFPID-0001",
"CSAFPID-0002",
"CSAFPID-0003",
"CSAFPID-0004",
"CSAFPID-0005",
"CSAFPID-0006"
]
},
{
"category": "vendor_fix",
"details": "Users should ensure the WBM is rebooted after configuration for their network(s) by removing the WBM from the rear of the Spectrum device for 10-15 seconds, and then re-attaching the WBM.",
"product_ids": [
"CSAFPID-0001",
"CSAFPID-0002",
"CSAFPID-0003",
"CSAFPID-0004",
"CSAFPID-0005",
"CSAFPID-0006"
]
},
{
"category": "vendor_fix",
"details": "Users should always monitor for and/or block unexpected traffic, such as FTP, at network boundaries into the Spectrum-specific VLAN.",
"product_ids": [
"CSAFPID-0001",
"CSAFPID-0002",
"CSAFPID-0003",
"CSAFPID-0004",
"CSAFPID-0005",
"CSAFPID-0006"
]
},
{
"category": "vendor_fix",
"details": "As a last resort, users may disable wireless operation of the pump. The Spectrum Infusion System was designed to operate without network access. This action would impact an organization \u0027s ability to rapidly deploy drug library (formulary) updates to their pumps.",
"product_ids": [
"CSAFPID-0001",
"CSAFPID-0002",
"CSAFPID-0003",
"CSAFPID-0004",
"CSAFPID-0005",
"CSAFPID-0006"
]
},
{
"category": "vendor_fix",
"details": "For additional information please see the Baxter Product Security Bulletin.",
"product_ids": [
"CSAFPID-0001",
"CSAFPID-0002",
"CSAFPID-0003",
"CSAFPID-0004",
"CSAFPID-0005",
"CSAFPID-0006"
],
"url": "https://www.baxter.com/product-security#additionalresources"
}
],
"scores": [
{
"cvss_v3": {
"baseScore": 8.6,
"baseSeverity": "HIGH",
"vectorString": "CVSS:3.0/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:H",
"version": "3.0"
},
"products": [
"CSAFPID-0001",
"CSAFPID-0002",
"CSAFPID-0003",
"CSAFPID-0004",
"CSAFPID-0005",
"CSAFPID-0006"
]
}
]
},
{
"cve": "CVE-2020-12041",
"cwe": {
"id": "CWE-732",
"name": "Incorrect Permission Assignment for Critical Resource"
},
"notes": [
{
"category": "summary",
"text": "The Baxter Spectrum WBM (v9, v11, v13, v14, v15, v16, v16D38, v17, v17D19, v20D29 to v20D32, and v22D19 to v22D28) Telnet Command-Line Interface grants access to sensitive data stored on the WBM that permits temporary configuration changes to network settings of the WBM. This access allows the WBM to be rebooted. Temporary configuration changes to network settings are removed upon reboot. CVE-2020-12041 has been assigned to this vulnerability. A CVSS v3 base score of 8.6 has been calculated; the CVSS vector string is (AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:H).",
"title": "Vulnerability Summary"
}
],
"product_status": {
"known_affected": [
"CSAFPID-0001",
"CSAFPID-0002",
"CSAFPID-0003",
"CSAFPID-0004",
"CSAFPID-0005",
"CSAFPID-0006"
]
},
"references": [
{
"category": "external",
"summary": "web.nvd.nist.gov",
"url": "http://web.nvd.nist.gov/view/vuln/detail?vulnId=CVE-2020-12041"
},
{
"category": "external",
"summary": "www.first.org",
"url": "https://www.first.org/cvss/calculator/3.0#CVSS:3.0/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:H"
}
],
"remediations": [
{
"category": "vendor_fix",
"details": "Baxter recommends ensuring appropriate physical controls within user environments to protect against unauthorized access to devices.",
"product_ids": [
"CSAFPID-0001",
"CSAFPID-0002",
"CSAFPID-0003",
"CSAFPID-0004",
"CSAFPID-0005",
"CSAFPID-0006"
]
},
{
"category": "vendor_fix",
"details": "Baxter recommends isolating the Spectrum Infusion Systems to its own network VLAN to segregate the system from other hospital systems, and reduce the probability that a threat actor could execute an adjacent attack such as a MiTM attack against the system to observe clear-text communications.",
"product_ids": [
"CSAFPID-0001",
"CSAFPID-0002",
"CSAFPID-0003",
"CSAFPID-0004",
"CSAFPID-0005",
"CSAFPID-0006"
]
},
{
"category": "vendor_fix",
"details": "Baxter recommends using the strongest available wireless network security protocols (e.g., WPA2, EAP-TLS, etc.) to provide authentication and encryption of wireless data sent to and from the Spectrum Infusion System.",
"product_ids": [
"CSAFPID-0001",
"CSAFPID-0002",
"CSAFPID-0003",
"CSAFPID-0004",
"CSAFPID-0005",
"CSAFPID-0006"
]
},
{
"category": "vendor_fix",
"details": "Users should ensure the WBM is rebooted after configuration for their network(s) by removing the WBM from the rear of the Spectrum device for 10-15 seconds, and then re-attaching the WBM.",
"product_ids": [
"CSAFPID-0001",
"CSAFPID-0002",
"CSAFPID-0003",
"CSAFPID-0004",
"CSAFPID-0005",
"CSAFPID-0006"
]
},
{
"category": "vendor_fix",
"details": "Users should always monitor for and/or block unexpected traffic, such as FTP, at network boundaries into the Spectrum-specific VLAN.",
"product_ids": [
"CSAFPID-0001",
"CSAFPID-0002",
"CSAFPID-0003",
"CSAFPID-0004",
"CSAFPID-0005",
"CSAFPID-0006"
]
},
{
"category": "vendor_fix",
"details": "As a last resort, users may disable wireless operation of the pump. The Spectrum Infusion System was designed to operate without network access. This action would impact an organization \u0027s ability to rapidly deploy drug library (formulary) updates to their pumps.",
"product_ids": [
"CSAFPID-0001",
"CSAFPID-0002",
"CSAFPID-0003",
"CSAFPID-0004",
"CSAFPID-0005",
"CSAFPID-0006"
]
},
{
"category": "vendor_fix",
"details": "For additional information please see the Baxter Product Security Bulletin.",
"product_ids": [
"CSAFPID-0001",
"CSAFPID-0002",
"CSAFPID-0003",
"CSAFPID-0004",
"CSAFPID-0005",
"CSAFPID-0006"
],
"url": "https://www.baxter.com/product-security#additionalresources"
}
],
"scores": [
{
"cvss_v3": {
"baseScore": 8.6,
"baseSeverity": "HIGH",
"vectorString": "CVSS:3.0/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:H",
"version": "3.0"
},
"products": [
"CSAFPID-0001",
"CSAFPID-0002",
"CSAFPID-0003",
"CSAFPID-0004",
"CSAFPID-0005",
"CSAFPID-0006"
]
}
]
},
{
"cve": "CVE-2020-12047",
"cwe": {
"id": "CWE-259",
"name": "Use of Hard-coded Password"
},
"notes": [
{
"category": "summary",
"text": "The factor-default wireless configuration of the Baxter Spectrum WBM (v17, v17D19, v20D29 to v20D32, and v22D19 to v22D28) enables File Transfer Protocol (FTP) service with hard-coded credentials. CVE-2020-12047 has been assigned to this vulnerability. A CVSS v3 base score of 7.3 has been calculated; the CVSS vector string is (AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:L).",
"title": "Vulnerability Summary"
}
],
"product_status": {
"known_affected": [
"CSAFPID-0001",
"CSAFPID-0002",
"CSAFPID-0003",
"CSAFPID-0004",
"CSAFPID-0005",
"CSAFPID-0006"
]
},
"references": [
{
"category": "external",
"summary": "web.nvd.nist.gov",
"url": "http://web.nvd.nist.gov/view/vuln/detail?vulnId=CVE-2020-12047"
},
{
"category": "external",
"summary": "www.first.org",
"url": "https://www.first.org/cvss/calculator/3.0#CVSS:3.0/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:L"
}
],
"remediations": [
{
"category": "vendor_fix",
"details": "Baxter recommends ensuring appropriate physical controls within user environments to protect against unauthorized access to devices.",
"product_ids": [
"CSAFPID-0001",
"CSAFPID-0002",
"CSAFPID-0003",
"CSAFPID-0004",
"CSAFPID-0005",
"CSAFPID-0006"
]
},
{
"category": "vendor_fix",
"details": "Baxter recommends isolating the Spectrum Infusion Systems to its own network VLAN to segregate the system from other hospital systems, and reduce the probability that a threat actor could execute an adjacent attack such as a MiTM attack against the system to observe clear-text communications.",
"product_ids": [
"CSAFPID-0001",
"CSAFPID-0002",
"CSAFPID-0003",
"CSAFPID-0004",
"CSAFPID-0005",
"CSAFPID-0006"
]
},
{
"category": "vendor_fix",
"details": "Baxter recommends using the strongest available wireless network security protocols (e.g., WPA2, EAP-TLS, etc.) to provide authentication and encryption of wireless data sent to and from the Spectrum Infusion System.",
"product_ids": [
"CSAFPID-0001",
"CSAFPID-0002",
"CSAFPID-0003",
"CSAFPID-0004",
"CSAFPID-0005",
"CSAFPID-0006"
]
},
{
"category": "vendor_fix",
"details": "Users should ensure the WBM is rebooted after configuration for their network(s) by removing the WBM from the rear of the Spectrum device for 10-15 seconds, and then re-attaching the WBM.",
"product_ids": [
"CSAFPID-0001",
"CSAFPID-0002",
"CSAFPID-0003",
"CSAFPID-0004",
"CSAFPID-0005",
"CSAFPID-0006"
]
},
{
"category": "vendor_fix",
"details": "Users should always monitor for and/or block unexpected traffic, such as FTP, at network boundaries into the Spectrum-specific VLAN.",
"product_ids": [
"CSAFPID-0001",
"CSAFPID-0002",
"CSAFPID-0003",
"CSAFPID-0004",
"CSAFPID-0005",
"CSAFPID-0006"
]
},
{
"category": "vendor_fix",
"details": "As a last resort, users may disable wireless operation of the pump. The Spectrum Infusion System was designed to operate without network access. This action would impact an organization \u0027s ability to rapidly deploy drug library (formulary) updates to their pumps.",
"product_ids": [
"CSAFPID-0001",
"CSAFPID-0002",
"CSAFPID-0003",
"CSAFPID-0004",
"CSAFPID-0005",
"CSAFPID-0006"
]
},
{
"category": "vendor_fix",
"details": "For additional information please see the Baxter Product Security Bulletin.",
"product_ids": [
"CSAFPID-0001",
"CSAFPID-0002",
"CSAFPID-0003",
"CSAFPID-0004",
"CSAFPID-0005",
"CSAFPID-0006"
],
"url": "https://www.baxter.com/product-security#additionalresources"
}
],
"scores": [
{
"cvss_v3": {
"baseScore": 7.3,
"baseSeverity": "HIGH",
"vectorString": "CVSS:3.0/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:L",
"version": "3.0"
},
"products": [
"CSAFPID-0001",
"CSAFPID-0002",
"CSAFPID-0003",
"CSAFPID-0004",
"CSAFPID-0005",
"CSAFPID-0006"
]
}
]
},
{
"cve": "CVE-2020-12043",
"cwe": {
"id": "CWE-672",
"name": "Operation on a Resource after Expiration or Release"
},
"notes": [
{
"category": "summary",
"text": "When configured for wireless networking, the Baxter Spectrum WBM (v17, v17D19, v20D29 to v20D32, and v22D19 to v22D28) enables FTP service operating on the WBM to remain operational until the WBM is rebooted. CVE-2020-12043 has been assigned to this vulnerability. A CVSS v3 base score of 7.3 has been calculated; the CVSS vector string is (AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:L).",
"title": "Vulnerability Summary"
}
],
"product_status": {
"known_affected": [
"CSAFPID-0001",
"CSAFPID-0002",
"CSAFPID-0003",
"CSAFPID-0004",
"CSAFPID-0005",
"CSAFPID-0006"
]
},
"references": [
{
"category": "external",
"summary": "web.nvd.nist.gov",
"url": "http://web.nvd.nist.gov/view/vuln/detail?vulnId=CVE-2020-12043"
},
{
"category": "external",
"summary": "www.first.org",
"url": "https://www.first.org/cvss/calculator/3.0#CVSS:3.0/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:L"
}
],
"remediations": [
{
"category": "vendor_fix",
"details": "Baxter recommends ensuring appropriate physical controls within user environments to protect against unauthorized access to devices.",
"product_ids": [
"CSAFPID-0001",
"CSAFPID-0002",
"CSAFPID-0003",
"CSAFPID-0004",
"CSAFPID-0005",
"CSAFPID-0006"
]
},
{
"category": "vendor_fix",
"details": "Baxter recommends isolating the Spectrum Infusion Systems to its own network VLAN to segregate the system from other hospital systems, and reduce the probability that a threat actor could execute an adjacent attack such as a MiTM attack against the system to observe clear-text communications.",
"product_ids": [
"CSAFPID-0001",
"CSAFPID-0002",
"CSAFPID-0003",
"CSAFPID-0004",
"CSAFPID-0005",
"CSAFPID-0006"
]
},
{
"category": "vendor_fix",
"details": "Baxter recommends using the strongest available wireless network security protocols (e.g., WPA2, EAP-TLS, etc.) to provide authentication and encryption of wireless data sent to and from the Spectrum Infusion System.",
"product_ids": [
"CSAFPID-0001",
"CSAFPID-0002",
"CSAFPID-0003",
"CSAFPID-0004",
"CSAFPID-0005",
"CSAFPID-0006"
]
},
{
"category": "vendor_fix",
"details": "Users should ensure the WBM is rebooted after configuration for their network(s) by removing the WBM from the rear of the Spectrum device for 10-15 seconds, and then re-attaching the WBM.",
"product_ids": [
"CSAFPID-0001",
"CSAFPID-0002",
"CSAFPID-0003",
"CSAFPID-0004",
"CSAFPID-0005",
"CSAFPID-0006"
]
},
{
"category": "vendor_fix",
"details": "Users should always monitor for and/or block unexpected traffic, such as FTP, at network boundaries into the Spectrum-specific VLAN.",
"product_ids": [
"CSAFPID-0001",
"CSAFPID-0002",
"CSAFPID-0003",
"CSAFPID-0004",
"CSAFPID-0005",
"CSAFPID-0006"
]
},
{
"category": "vendor_fix",
"details": "As a last resort, users may disable wireless operation of the pump. The Spectrum Infusion System was designed to operate without network access. This action would impact an organization \u0027s ability to rapidly deploy drug library (formulary) updates to their pumps.",
"product_ids": [
"CSAFPID-0001",
"CSAFPID-0002",
"CSAFPID-0003",
"CSAFPID-0004",
"CSAFPID-0005",
"CSAFPID-0006"
]
},
{
"category": "vendor_fix",
"details": "For additional information please see the Baxter Product Security Bulletin.",
"product_ids": [
"CSAFPID-0001",
"CSAFPID-0002",
"CSAFPID-0003",
"CSAFPID-0004",
"CSAFPID-0005",
"CSAFPID-0006"
],
"url": "https://www.baxter.com/product-security#additionalresources"
}
],
"scores": [
{
"cvss_v3": {
"baseScore": 7.3,
"baseSeverity": "HIGH",
"vectorString": "CVSS:3.0/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:L",
"version": "3.0"
},
"products": [
"CSAFPID-0001",
"CSAFPID-0002",
"CSAFPID-0003",
"CSAFPID-0004",
"CSAFPID-0005",
"CSAFPID-0006"
]
}
]
}
]
}
Loading…
Loading…
Sightings
| Author | Source | Type | Date |
|---|
Nomenclature
- Seen: The vulnerability was mentioned, discussed, or observed by the user.
- Confirmed: The vulnerability has been validated from an analyst's perspective.
- Published Proof of Concept: A public proof of concept is available for this vulnerability.
- Exploited: The vulnerability was observed as exploited by the user who reported the sighting.
- Patched: The vulnerability was observed as successfully patched by the user who reported the sighting.
- Not exploited: The vulnerability was not observed as exploited by the user who reported the sighting.
- Not confirmed: The user expressed doubt about the validity of the vulnerability.
- Not patched: The vulnerability was not observed as successfully patched by the user who reported the sighting.
Loading…
Loading…